334 related articles for article (PubMed ID: 26654154)
1. A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine characteristics of women with polycystic ovary syndrome.
Javanmanesh F; Kashanian M; Rahimi M; Sheikhansari N
Gynecol Endocrinol; 2016; 32(4):285-9. PubMed ID: 26654154
[TBL] [Abstract][Full Text] [Related]
2. Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome.
Oner G; Muderris II
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):127-31. PubMed ID: 21831508
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy between NAC and metformin in treating PCOS patients: a meta-analysis.
Song Y; Wang H; Huang H; Zhu Z
Gynecol Endocrinol; 2020 Mar; 36(3):204-210. PubMed ID: 31749393
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a randomized controlled study.
Trolle B; Lauszus FF; Frystyk J; Flyvbjerg A
Fertil Steril; 2010 Nov; 94(6):2234-8. PubMed ID: 20189560
[TBL] [Abstract][Full Text] [Related]
5. N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study.
Elnashar A; Fahmy M; Mansour A; Ibrahim K
Fertil Steril; 2007 Aug; 88(2):406-9. PubMed ID: 17335818
[TBL] [Abstract][Full Text] [Related]
6. Effect of metformin and pioglitazone treatment on cardiovascular risk profile in polycystic ovary syndrome.
Ziaee A; Oveisi S; Abedini A; Hashemipour S; Karimzadeh T; Ghorbani A
Acta Med Indones; 2012 Jan; 44(1):16-22. PubMed ID: 22451180
[TBL] [Abstract][Full Text] [Related]
7. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of abdominal acupuncture for patients with obesity-type polycystic ovary syndrome: a randomized controlled trial.
Zheng YH; Wang XH; Lai MH; Yao H; Liu H; Ma HX
J Altern Complement Med; 2013 Sep; 19(9):740-5. PubMed ID: 23676106
[TBL] [Abstract][Full Text] [Related]
9. Increased endothelin-1 levels in women with polycystic ovary syndrome and the beneficial effect of metformin therapy.
Diamanti-Kandarakis E; Spina G; Kouli C; Migdalis I
J Clin Endocrinol Metab; 2001 Oct; 86(10):4666-73. PubMed ID: 11600523
[TBL] [Abstract][Full Text] [Related]
10. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
[TBL] [Abstract][Full Text] [Related]
11. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
Singh S; Akhtar N; Ahmad J
Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
[TBL] [Abstract][Full Text] [Related]
13. Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial.
Shokrpour M; Foroozanfard F; Afshar Ebrahimi F; Vahedpoor Z; Aghadavod E; Ghaderi A; Asemi Z
Gynecol Endocrinol; 2019 May; 35(5):406-411. PubMed ID: 30608001
[TBL] [Abstract][Full Text] [Related]
14. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome.
Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L
J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of glucose-insulin ratio in PCOS and profile of women who will benefit from metformin therapy: obese, lean, hyper or normoinsulinemic?
Onalan G; Goktolga U; Ceyhan T; Bagis T; Onalan R; Pabuçcu R
Eur J Obstet Gynecol Reprod Biol; 2005 Dec; 123(2):204-11. PubMed ID: 16316811
[TBL] [Abstract][Full Text] [Related]
16. [Advantages of Chinese medicine for treatment of blood sugar and lipid metabolic disorders in patients with polycystic ovarian syndrome].
Zhao H; Bao WF; Zhang T
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jul; 29(7):595-8. PubMed ID: 19852289
[TBL] [Abstract][Full Text] [Related]
17. The effect of alfacalcidiol and metformin on metabolic disturbances in women with polycystic ovary syndrome.
Figurová J; Dravecká I; Petríková J; Javorský M; Lazúrová I
Horm Mol Biol Clin Investig; 2017 Mar; 29(3):85-91. PubMed ID: 28157691
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profile of Diane-35 versus Diane-35 plus metformin in Chinese PCOS women under standardized life-style changes.
Wu H; Ruan X; Jin J; Mueck AO
Gynecol Endocrinol; 2015 Jul; 31(7):548-51. PubMed ID: 26004979
[TBL] [Abstract][Full Text] [Related]
19. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation.
Moghetti P; Castello R; Negri C; Tosi F; Perrone F; Caputo M; Zanolin E; Muggeo M
J Clin Endocrinol Metab; 2000 Jan; 85(1):139-46. PubMed ID: 10634377
[TBL] [Abstract][Full Text] [Related]
20. Can metformin reduce insulin resistance in polycystic ovary syndrome?
Açbay O; Gündoğdu S
Fertil Steril; 1996 May; 65(5):946-9. PubMed ID: 8612854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
